Lv41
422 积分 2024-05-28 加入
Overcoming target interference in bridging anti-drug antibody (ADA) assay by optimizing sample treatment
6天前
已完结
Drug Removal Strategies in Competitive Ligand Binding Neutralizing Antibody (NAb) Assays: Highly Drug-Tolerant Methods and Interpreting Immunogenicity Data
6天前
已完结
Application and interpretation of free and total drug measurements in the development of biologics
1个月前
已完结
Theoretical Analysis of Interplay of Therapeutic Protein Drug and Circulating Soluble Target: Temporal Profiles of ‘Free’ and ‘Total’ Drug and Target
1个月前
已完结
Target Occupancy Biomarker Assay Development Using a Conformation-Selective Antibody Against Small-Molecule-Bound TNF
1个月前
已完结
Detection of Cancer Biomarkers: Review of Methods and Applications Reported from Analytical Perspective
2个月前
已完结
Immunogenicity Assessment of Inotersen, a 2′-O-(2-Methoxyethyl) Antisense Oligonucleotide in Animals and Humans: Effect on Pharmacokinetics, Pharmacodynamics, and Safety
2个月前
已完结
Overcoming Soluble Target Interference in Measurement of Total Bispecific Therapeutic Antibody Concentrations
2个月前
已完结
Screening Non-neutralizing Anti-idiotype Antibodies Against a Drug Candidate for Total Pharmacokinetic and Target Engagement Assay
2个月前
已完结
Free and total biotherapeutic evaluation in chromatographic assays: interference from targets and immunogenicity
2个月前
已完结
皖公网安备34019202002308
